Press Releases

Date	Title	File/s
May 06, 2026	Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 01, 2026	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Apr 29, 2026	Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6
Apr 27, 2026	Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting
Apr 03, 2026	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mar 19, 2026	Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update
Mar 12, 2026	Taysha Gene Therapies to Release Full-Year 2025 Financial Results and Host Conference Call and Webcast on March 19
Mar 06, 2026	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Feb 06, 2026	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jan 06, 2026	Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome